Daniel Loeb

Daniel Loeb

Last Update: 05-15-2017

Number of Stocks: 39
Number of New Stocks: 12

Total Value: $10,248 Mil
Q/Q Turnover: 16%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

Daniel Loeb Watch

  • Daniel Loeb Buys JPMorgan, Time Warner, Bank of America

    Daniel Loeb (Trades, Portfolio) founded Third Point LLC in 1995 and leads the firm’s research activities, portfolio and risk management. During the fourth quarter of 2016, he bought shares in the following stocks:

    The investor purchased 5,250,000 shares of JPMorgan Chase & Co. (NYSE:JPM), establishing a postion. The trade had an impact of 4.45% on the portfolio.


  • Daniel Loeb Picks Up Rate-Sensitive Financials, Drops Pharma

    Daniel Loeb (Trades, Portfolio)’s weighting in financial services expanded to 14.4% from 6.3% in the fourth quarter, as he bought shares of three big banks and nixed several positions in health care.

    The manager of Third Point hedge fund dropped pharma company Allergan (NYSE:AGN) from his portfolio after blaming it and Amgen (NASDAQ:AMGN) for low returns in his equity portfolio, which gained 6.1% for the quarter, versus a 12% rise in the S&P 500. Loeb opted for more balance entering January, but shifted his strategy when Donald Trump’s victory in the 2016 presidential election took him by surprise.


  • Daniel Loeb's Third Point Hedge Fund 4th Quarter Commentary

    Review and Outlook


  • 5 Stocks That Have Gotten Cheaper in Market's All-Time High

    President Donald Trump takes credit for many things, but he can unmistakably be credited for the market’s sudden rise to record highs since his victory in the Electoral College. While the S&P 500 has gained 5.6% since Nov. 8, not all companies have benefited from the so-called “Trump bump,” particularly in sectors cowering from negative projections of his stated opinions and policies.

    Health care, hanging in limbo with the potential repeal of Obamacare looming, is the only S&P 500 sector to decline in the past year. It’s down 2.35%, though its constituents still carry a relatively high P/E of 32.02, compared to 26.1 for the index. A closer look shows that the two health care industries to fall the most over the past year also had the highest valuations. Health Care Technology, down 20.3%, had a P/E of 118.6 last year; Biotechnology, docked 11.2%, had a P/E of 46.


  • Steve Mandel Expands Consumer Cyclical Empire in 3rd Quarter

    Steve Mandel (Trades, Portfolio), a long-short equity money manager, founded Lone Pine Capital in 1997. The guru invests in companies with a fundamental analysis and bottom-up approach, which incorporates both value and growth methodologies. He expanded his consumer cyclical empire in the third quarter by investing in two travel companies and two online retail companies.



  • David Tepper Expands Technology and Financial Empire

    David Tepper (Trades, Portfolio), founder of Appaloosa Management, has earned a reputation for producing top market returns among Wall Street guru investors. The distressed debt specialist primarily invests in companies at cheap prices and sells them as the stock price increases.

    During the third quarter, Tepper invested in 12 companies, five of which are in the technology or financial services sectors.


  • Daniel Loeb Buys Apple, Online Stocks

    Daniel Loeb (Trades, Portfolio) bought nine stocks in the third quarter, but the majority was of tech and internet companies.

    Buying 2.5 million shares, Loeb’s $282.6 million stake in Apple Inc. (NASDAQ:AAPL) was his largest new holding and one he bought after its price dipped by 9% in the first half. Loeb has weaved in and out of Apple in the past, last ousting a stake in the fourth quarter 2014 at an average price around $76. He bought back in at a quarterly average price around $106.  

  • A High-Tech Manufacturer With Excellent Growth Prospects

    When AMETEK (NYSE:AME) reported its third-quarter results Tuesday, it continued its give-and-take story of this year: gains from recent acquisitions and losses from exposure to the oil and gas industry.

    AMETEK designs and manufactures electronic instruments, electromechanical devices and other products. It specializes in products that demand high precision or accuracy, and these differentiated products help it generate strong margins.


  • Daniel Loeb Comments on Akarna Therapeutics

    Akarna Therapeutics TPV was a founding investor in Akarna in Q1 2015. Akarna focuses on the treatment of Nonalcoholic Steatohepatitis (NASH), also known as fatty liver disease. Akarna was attractive for several reasons:

    • Large market opportunity: Epidemiologic studies suggest that NASH affects 2 – 5% of Americans and is believed to be correlated with increasing rates of obesity, diabetes, and high cholesterol. If left untreated, NASH can lead to liver fibrosis, cirrhosis, and, ultimately, end-stage liver disease. Unfortunately, there are no currently approved treatments for NASH.

  • Daniel Loeb Comments on Apigee

    TPV initially invested in Apigee (NASDAQ:APIC) in July 2008 when the company was known as Sonoa Systems. The company originally targeted their hardware appliance-based technology at Systems Oriented Architecture (SOA), challenging the industry-leading IBM as enterprises quickly developed to connect application elements over networks. After recognizing in 2010 that there was a transformational opportunity to apply Sonoa’s core technology, Third Point Ventures helped the company rebrand itself as Apigee and pivot to a focus on enterprise digital transformation via a software platform for APIs (Application Programming Interfaces).

    Since then, APIs have become the highway for the fast-moving digital economy. Apigee’s industry-leading API platform enables enterprises to meet the demands of customers with scalable and flexible digital technology. API platforms allow businesses to increase innovation while adapting to highly variable customer needs by securely providing shared data and services. The Apigee Edge API Management Platform connects digital experiences in a secure environment. Apigee’s API platform delivers analytics, security, developer portals, monetization, and policy enforcement. Since 2010, over 300 leading global enterprises have selected Apigee to enable their digital business, including more than 30% of the Fortune 100, four of the top five Global 2000 retail companies, and five of the top ten global telecommunications companies.


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat